Pravachol Generic Takes Its Toll On Bristol’s Pharma Sales

Global Sales of Bristol-Myers Squibb's blockbuster cholesterol drug Pravachol tumbled 48.3% to $323 mil. in the second quarter following the launch of generic pravastatin early in the quarter